CLINICAL_TRIALS ClinicalTrials.gov record update

A Long-Term, Open-Label, Prospective Phase IV Study to Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03256838
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:26.810244+00:00
Published At: 2020-01-13T00:00:00+00:00
Record Updated At: 2020-01-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Kidney Failure, Chronic", "End-stage Renal Disease", "Phosphorus Metabolism Disorders", "Hyperphosphatemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-01-13"
protocolSection.identificationModule.nctId: "NCT03256838"
protocolSection.identificationModule.officialTitle: "A Long-Term, Open-Label, Prospective Phase IV Study to Assess the Safety and Efficacy of Nephoxil\u00ae in Subjects With End Stage Renal Disease (ESRD) on Dialysis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.